MTOR and central nervous system cancer: Importantly, levels of alanine, 2HG, glutamate, glutamine and aspartate were significantly reduced in XL765-treated cells in both of our models, thus identifying potentially translational metabolic biomarkers of IDHmut glioma cell response to PI3K/mTOR inhibition.